OK a bit liberal with dates.
from 14 March pre FDA meeting;
"The Company also confirms that it will perform pivotal clinical studies at one or more US hospitals to provide a key portion of the clinical data required to support both paediatric and adult submissions. The balance of the required data will be gathered from pivotal studies at previously established Australian sites.
Dont need a clown suit as failed Senior English, but I read that to mean the majority of testing in The USA.
So I figure that the majority of the testing in the USA, will take a year or more from when they start. That puts it 6 months behind schedule, which in effect is what I was inferring in a round a bout way indirectly,without being precise.
- Forums
- ASX - By Stock
- RAP
- Ann: Appendix 3B-RAP.AX
Ann: Appendix 3B-RAP.AX, page-15
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online